Fig. 1. (A) Evaluation of bone marrow stem cells (BMSCs)’s shape on Day 3 in growth media (×100). Scale bars=400 μm. (B) Qualitative cellular viability results under a confocal microscope on Day 4. Live images, dead images, merged images, and central images are provided. (C) Cellular viability using CCK-8 assay at Days 1 and 3 among different age groups. *Statistically significant differences were noted when compared with the results of the 30s group on Day 1. (D) Cellular viability using CCK-8 assay at Days 1 and 3 in males and females. *Statistically significant differences were noted when compared with the results of males on Day 1.
Fig. 2. (A) Expression of stem cell immunophenotype observed with flow cytometry. The bone marrow stem cells (BMSCs) in all groups expressed CD44, CD73, and CD90 surface antigens but did not express CD14 or CD34. (B) Expression of the stem cell markers SSEA-4. (C) Secretion of vascular endothelial growth factors from BMSCs among different age groups. *Statistically significant differences were noted when compared with the results of the 20s group on Day 2. **Statistically significant differences were noted when compared with the results of the 20s group on Day 2. ***Statistically significant differences were noted when compared with the results of 30s group on Day 2. ****Statistically significant differences were noted when compared with the results of the 30s group on Day 2. (D) Secretion of vascular endothelial growth factors in males and females. *Statistically significant differences were noted when compared with the results of males on Day 3. **Statistically significant differences were noted when compared with the results of males on Day 2. ***Statistically significant differences were noted when compared with the results of females on Day 2.
Fig. 3. (A) Runx2 gene expression of human bone marrow-derived stem cells (hBMSCs) according to age. *Statistically significant differences were noted when compared with the results of the 20s group on Day 2. (B) Runx2 gene expression of hBMSCs according to sex. (C) Collagen I gene expression of hBMSCs according to age. *Statistically significant differences were noted when compared with the results of the 20s group on Day 2. (D) Collagen I gene expression of hBMSCs according to sex.
Fig. 4. (A) Western blot analysis to detect the protein expressions of Runx2, collagen I and GAPDH. (B) Quantitative analysis was performed to show levels of Runx2 according to age. (C) Runx2 expression according to sex. (D) Quantitative analysis of collagen I expression according to age.
References
- Peptanariu D, Zlei M, Negura A, Carasevici E. Optimization of culture conditions for bone marrow stromal cells in RPMI-1640 medium. Rev Med Chir Soc Med Nat Iasi. 2012; 116: 222-7.
- Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem. 1999; 72: 570-85. https://doi.org/10.1002/(SICI)1097-4644(19990315)72:4<570::AID-JCB12>3.0.CO;2-W
- Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001; 19: 180-92. https://doi.org/10.1634/stemcells.19-3-180
- Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000; 28: 875-84. https://doi.org/10.1016/S0301-472X(00)00482-3
- Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995; 92: 4857-61. https://doi.org/10.1073/pnas.92.11.4857
- Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24: 1294-301. https://doi.org/10.1634/stemcells.2005-0342
- Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, Kim SW, Yang YS, Oh W, Chang JW. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013; 14: 17986-8001. https://doi.org/10.3390/ijms140917986
- Fehrer C, Laschober G, Lepperdinger G. Aging of murine mesenchymal stem cells. Ann N Y Acad Sci. 2006; 1067: 235-42. https://doi.org/10.1196/annals.1354.030
- Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006; 5: 91-116. https://doi.org/10.1016/j.arr.2005.10.001
- Stolzing A, Jones E, McGonagle D, Scutt A. Agerelated changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008; 129: 163-73. https://doi.org/10.1016/j.mad.2007.12.002
- Mets T, Verdonk G. In vitro aging of human bone marrow derived stromal cells. Mech Ageing Dev. 1981; 16: 81-9. https://doi.org/10.1016/0047-6374(81)90035-X